Skip to main content
Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.399
-0.001 (-0.25%)
At close: Mar 6, 2026

Elite Pharmaceuticals Revenue

Elite Pharmaceuticals had revenue of $31.59M in the quarter ending December 31, 2025, with 119.92% growth. This brings the company's revenue in the last twelve months to $140.12M, up 100.18% year-over-year. In the fiscal year ending March 31, 2025, Elite Pharmaceuticals had annual revenue of $84.04M with 48.42% growth.

Revenue (ttm)
140.12M
Revenue Growth
+100.18%
P/S Ratio
3.07
Revenue / Employee
2.06M
Employees
68
Market Cap
429.68M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202584.04M27.42M48.42%
Mar 31, 202456.63M22.47M65.79%
Mar 31, 202334.16M1.89M5.87%
Mar 31, 202232.26M6.88M27.11%
Mar 31, 202125.38M7.39M41.05%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Glass House Brands 196.17M
Jushi Holdings 260.43M
Growth Stalk Holdings 583.34K
Sofgen Pharma 423.75M
Radnostix 14.07M
Healthy Extracts 3.59M
MariMed 157.38M
Earth Science Tech 34.87M
Revenue Rankings

Elite Pharmaceuticals News

More News